Viatris Inc. (VIA.DE)
| Previous close | 10.46 |
| Open | 10.34 |
| Bid | 10.34 x N/A |
| Ask | 10.45 x N/A |
| Day's range | 10.32 - 10.50 |
| 52-week range | 8.16 - 12.60 |
| Volume | |
| Avg. volume | 3,552 |
| Market cap | 12.422B |
| Beta (5Y monthly) | 1.15 |
| PE ratio (TTM) | 209.20 |
| EPS (TTM) | 0.05 |
| Earnings date | 06 May 2024 - 10 May 2024 |
| Forward dividend & yield | 0.44 (4.22%) |
| Ex-dividend date | 08 Mar 2024 |
| 1y target est | N/A |
Zacks3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to RDY, TEVA and VTRS.
Insider MonkeyBill Miller’s Latest 13 Stock Picks
In this piece, we will take a look at Bill Miller’s latest stock picks. If you want to skip our overview of Miller, his firm, and the latest news revolving around his hedge fund, then you can skip ahead to Bill Miller’s Latest 5 Stock Picks. Legendary value investor Bill Miller is the founder, Chairman, […]
PR NewswireViatris to Report First Quarter 2024 Financial Results on May 9, 2024
Viatris Inc. (NASDAQ: VTRS) will report its first quarter 2024 financial results on Thursday, May 9, 2024, before the open of the U.S. financial markets. Chief Executive Officer Scott A. Smith and other Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.
